Maxion Therapeutics Awarded £2 Million Innovate UK Funding to Develop Ion Channel Antibodies for “Hard-To-Treat’ Autoimmune Diseases
Funding targets a critical unmet clinical need to treat autoimmunity, which affects around 300 million people globally
Awarded...